Biotechnology Does BioNTech SE Sponsored ADR (BNTX) Have the Potential to Rally 48% as Wall Street Analysts Expect? July 12, 2022
Biotechnology Allogene Therapeutics Appoints Scientific Pioneer Stephen Mayo to its Board of Directors July 12, 2022
Biotechnology Leap Therapeutics Announces Initiation of New DKN-01 Clinical Trials in Gastric Cancer, Colorectal Cancer and Endometrial Cancer July 12, 2022
Biotechnology BIO-TECHNE LAUNCHES NEW TURBO CE-SDS(TM) CARTRIDGE, ACCELERATING PROTEIN PURITY ANALYSIS THROUGHPUT BY 400% July 12, 2022
Biotechnology LAWSUITS FILED AGAINST AXSM, NOTV and OM – JAKUBOWITZ LAW PURSUES SHAREHOLDERS CLAIMS July 11, 2022
Biotechnology AXSM FINAL DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Axsome Therapeutics, Inc. Investors With Losses to Secure Counsel Before Important July 12 Deadline in Securities Class Action – AXSM July 11, 2022
Biotechnology BioMarin Presents Findings from Studies of Valoctocogene Roxaparvovec, Investigational Gene Therapy, at the International Society on Thrombosis and Haemostasis (ISTH) 2022 Congress July 9-12, Including 4 Oral and 2 Poster Presentations July 11, 2022